These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31137083)

  • 21. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
    Herrero Álvarez N; Bauer D; Hernández-Gil J; Lewis JS
    ChemMedChem; 2021 Oct; 16(19):2909-2941. PubMed ID: 33792195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutron-activated theranostic radionuclides for nuclear medicine.
    Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
    Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with
    Talip Z; Favaretto C; Geistlich S; Meulen NPV
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32093425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour targeting with radiometals for diagnosis and therapy.
    Ramogida CF; Orvig C
    Chem Commun (Camb); 2013 May; 49(42):4720-39. PubMed ID: 23599005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of radiometallic compounds for medical diagnosis and therapy].
    Saji H
    Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and Use of the First-Row Transition Metal PET Radionuclides
    Chaple IF; Lapi SE
    J Nucl Med; 2018 Nov; 59(11):1655-1659. PubMed ID: 30262514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.
    Fersing C; Masurier N; Rubira L; Deshayes E; Lisowski V
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical optimization of production by deuteron irradiation of high specific activity (177g)Lu suitable for radioimmunotherapy.
    Manenti S; Bonardi ML; Gini L; Groppi F
    Nucl Med Biol; 2014; 41(5):407-9. PubMed ID: 24666720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
    Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
    J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of Zr-89 using sputtered yttrium coin targets
    Queern SL; Aweda TA; Massicano AVF; Clanton NA; El Sayed R; Sader JA; Zyuzin A; Lapi SE
    Nucl Med Biol; 2017 Jul; 50():11-16. PubMed ID: 28376350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Mou L; Martini P; Pupillo G; Cieszykowska I; Cutler CS; Mikołajczak R
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactor production and electrochemical purification of (169)Er: a potential step forward for its utilization in in vivo therapeutic applications.
    Chakravarty R; Chakraborty S; Chirayil V; Dash A
    Nucl Med Biol; 2014 Feb; 41(2):163-70. PubMed ID: 24480267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiometal complexes in molecular imaging and therapy.
    Rey AM
    Curr Med Chem; 2010; 17(31):3673-83. PubMed ID: 20846111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.
    Satterlee AB; Huang L
    Theranostics; 2016; 6(7):918-29. PubMed ID: 27217828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Click Chemistry and Radiochemistry: The First 10 Years.
    Meyer JP; Adumeau P; Lewis JS; Zeglis BM
    Bioconjug Chem; 2016 Dec; 27(12):2791-2807. PubMed ID: 27787983
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Rizvi SFA; Naqvi SAR; Roohi S; Sherazi TA; Rasheed R
    Mol Biol Rep; 2018 Dec; 45(6):1759-1767. PubMed ID: 30143975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theranostics: combining imaging and therapy.
    Kelkar SS; Reineke TM
    Bioconjug Chem; 2011 Oct; 22(10):1879-903. PubMed ID: 21830812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.